
zzso vascular zzso growth factor zzso zzso constitutes currently the zzso treatment in zzso age-related zzso zzso zzso By zzso application of the drug, the dosage can be kept low while maximizing its effect on zzso zzso and minimizing potential adverse systemic zzso However, the zzso barrier is often disrupted in zzso zzso disorders and the drugs can be detected in circulating blood despite being administered as an zzso zzso As patients with zzso constitute a high-risk population for cardiovascular events, the safety of zzso therapies must be precisely and thoroughly zzso In the present work, the recent reports documenting systemic safety of zzso zzso zzso have been zzso Moreover, the novel methods to assess the potential systemic effect on vascular zzso as the consequence of such therapy have been also zzso 

